SerbinCommunications

(805) 963-0439 | Toll-Free (800) 876-6425

www.serbin.com LA / NY / UK

Lucentis Mode of Action 

Prev Next
Previous

inside-Out View of Eye Chart

medical illustration of This painting received an Rx Club Award of Excellence. It depicts the mode of action of the drug Lucentis used in the treatment of wet age-related macular degeneration (wet AMD). The scene shows the stylized drug molecules binding and inactivating VEGF molecules (involved in the pathogenesis of the disease) within the choroid layer of the eye.
Next medical illustration of This illustration received the RX Club Award of Excellence. It is a modified still extracted from a 3D mode-of-action animated video created by Geras Healthcare Productions. It was used in print materials associated with the drug Lucentis. The illustration shows the pathologic changes to the macula, retina and choroidal blood vessels typical of advanced wet age-related macular degeneration (wet AMD).

Wet Age-Related Macular Degeneration

This painting received an Rx Club Award of Excellence. It depicts the mode of action of the drug Lucentis used in the treatment of wet age-related macular degeneration (wet AMD). The scene shows the stylized drug molecules binding and inactivating VEGF molecules (involved in the pathogenesis of the disease) within the choroid layer of the eye.

Keywords: 3D, Models, Advertising / Marketing, Editorial, Web, Allergy / Immunology, Biotechnology, Cell biology / Histology, Disease Management, Ophthalmology

© Audra Geras